| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/20/1993 | US5204323 Heparin and hirudin antidotal compositions and methods |
| 04/20/1993 | US5204259 Methods and systems for producing HIV antigens |
| 04/20/1993 | US5204258 DNA segment not expressing functional tat protein having ability to trans-activate; not containing entire HIV genome; for developing vaccines, detecting HTLV |
| 04/20/1993 | US5204256 Preincubating a solution with a disulfide-cleaving agent; mixing with an acridine or quinoline to precipitate impurities |
| 04/20/1993 | US5204097 Shiga toxin B chain polypeptides and vaccine thereto |
| 04/20/1993 | US5204096 Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 04/20/1993 | CA1316632C Immunologically active synthetic peptides useful for preparing an antimalarial vaccine |
| 04/20/1993 | CA1316631C Protein copolymer malaria vaccine |
| 04/20/1993 | CA1316630C Phosphinylcycloalkylcarbonyl and phosphinylcycloalkenylcarbonyl dipeptides |
| 04/20/1993 | CA1316479C Process for the production of vaccine for prevention of pasteurella haemolytica pneumonia in bovine |
| 04/20/1993 | CA1316475C Transformation somatic embryogenesis and whole plant regeneration method for glycine species |
| 04/20/1993 | CA1316474C Immunogenic conjugates of e. coli lt-b enterotoxin subunit and capsular polymers |
| 04/18/1993 | CA2080713A1 Monoclonal antibodies against mycoplasma pneumoniae, hybridomas producing these, methods for the preparation thereof, and the use thereof |
| 04/17/1993 | WO1993008292A1 Particle-mediated transformation of animal somatic cells |
| 04/17/1993 | WO1993008213A1 Novel physiologically active substance epimorphine, gene which codes for same, and antibody against epimorphine |
| 04/17/1993 | WO1993007892A1 Composition and treatment with biologically active peptides and antibiotic |
| 04/17/1993 | CA2120337A1 Composition and treatment with biologically active peptides and antibiotic |
| 04/17/1993 | CA2098599A1 Particle-mediated transformation of animal somatic cells |
| 04/17/1993 | CA2080525A1 Neutrophil activating factors |
| 04/16/1993 | CA2080502A1 Method for producing synthetic n-linked glycoconjugates |
| 04/15/1993 | WO1993007492A1 Preparation of prothrombin time reagents from recombinant human tissue factor and purified natural and synthetic phospholipids |
| 04/15/1993 | WO1993007490A1 Diagnostic and prognostic materials and methods |
| 04/15/1993 | WO1993007485A1 Rare immunoglobulin framework regions associated with human disease |
| 04/15/1993 | WO1993007296A1 Method for screening for alzheimer's disease |
| 04/15/1993 | WO1993007288A1 Macrophage activating factor from animal vitamin d-binding protein |
| 04/15/1993 | WO1993007286A1 Recombinant immunotoxins |
| 04/15/1993 | WO1993007283A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 04/15/1993 | WO1993007281A1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
| 04/15/1993 | WO1993007280A1 Astrocyte-specific transcription of human genes |
| 04/15/1993 | WO1993007278A1 Synthetic dna sequence having enhanced insecticidal activity in maize |
| 04/15/1993 | WO1993007274A1 Molecular cloning of pneumocystis carinii surface antigens and their use for the detection of pneumocystis carinii |
| 04/15/1993 | WO1993007273A1 Helicobacter pylori genes necessary for the regulation and maturation of urease, and use thereof |
| 04/15/1993 | WO1993007271A1 Osteoclast colony stimulating factor (o-csf) |
| 04/15/1993 | WO1993007270A1 Production of gpa neurotrophic factor |
| 04/15/1993 | WO1993007269A1 ISOLATION OF AN Mr 52,000 FK506 BINDING PROTEIN AND MOLECULAR CLONING OF A CORRESPONDING HUMAN cDNA |
| 04/15/1993 | WO1993007268A1 Soluble forms of elam, uses and diagnostics |
| 04/15/1993 | WO1993007267A1 Nucleic sequence of the gene associated with x-linked kallmann syndrome, corresponding peptide sequences, diagnostic applications |
| 04/15/1993 | WO1993007266A1 Genetic construct for selection of homologous recombinants on a single selective medium |
| 04/15/1993 | WO1993007265A1 Treatment of cystic fibrosis |
| 04/15/1993 | WO1993007264A1 Control of deleterious responses to ethylene in plants |
| 04/15/1993 | WO1993007262A2 Purified chitin deacetylase |
| 04/15/1993 | WO1993007175A1 Process for producing protein/synthetic polymer complex and said complex produced thereby |
| 04/15/1993 | WO1993007174A1 Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto |
| 04/15/1993 | WO1993007173A1 Transforming growth factor-e |
| 04/15/1993 | WO1993007172A1 Subunit vaccine for neisseria meningitidis infections and corresponding purified subunits |
| 04/15/1993 | WO1993007171A1 Human il-3 variants |
| 04/15/1993 | WO1993007170A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 04/15/1993 | WO1993007169A1 Peptide inhibitors of platelet adhesion |
| 04/15/1993 | WO1993007165A1 Lipoprotein assays using antibodies to a pan native epitope and recombinant antigens |
| 04/15/1993 | WO1993007161A1 Molecular cloning and transformation of cyclodiene resistance |
| 04/15/1993 | WO1993006868A1 Dendrimeric polychelants |
| 04/15/1993 | WO1993006867A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 04/15/1993 | WO1993006866A2 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 04/15/1993 | WO1993006864A1 Preventing allograft rejection with antibodies to adhesion molecules |
| 04/15/1993 | WO1993006861A1 Vaccine for neisseria meningitidis infections |
| 04/15/1993 | WO1993006859A1 Sperm surface protein |
| 04/15/1993 | WO1993006858A1 Lung cancer-associated protein |
| 04/15/1993 | WO1993006857A1 Preparation and use of human trophoblast membrane expressed protein in an anti-fertility vaccine |
| 04/15/1993 | WO1993006853A1 Cell damage repairing factor |
| 04/15/1993 | WO1993006852A2 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 04/15/1993 | WO1993006851A1 Mammalian gap-43 compositions and methods of use |
| 04/15/1993 | WO1993006850A1 Plasmodium falciparum-infected erythrocytes binding to icam-1 and cd36 |
| 04/15/1993 | WO1993006849A1 Binding of plasmodium falciparum-infected erythrocytes to cd36 |
| 04/15/1993 | WO1993006848A1 Cd36 immunoadhesins and their use in selectively killing plasmodium falciparum infected erythrocytes |
| 04/15/1993 | WO1993006846A1 Parathyroid hormone analogues and use in osteoporosis treatment |
| 04/15/1993 | WO1993006845A1 PARATHYROID HORMONE ANALOGUES SUBSTITUTED AT aa?25,26,27¿ AND USE IN OSTEOPOROSIS TREATMENT |
| 04/15/1993 | WO1993006844A1 Hormone analogs with multiple ctp extensions |
| 04/15/1993 | WO1993006843A1 Peptides corresponding to antigenic determinants of htlv |
| 04/15/1993 | WO1993006842A1 Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma |
| 04/15/1993 | WO1993006836A1 Von willebrand factor-specific heparin fractions |
| 04/15/1993 | WO1993006835A1 Leukocyte adhesion molecule-1 (lam-1) and ligand thereof |
| 04/15/1993 | WO1993006741A1 Method of extracting proteins utilizable in foodstuffs from a protein-containing substance |
| 04/15/1993 | WO1993006713A1 Monocot having dicot wound inducible promoter |
| 04/15/1993 | WO1993006710A1 Pathogen-resistant transgenic plants |
| 04/15/1993 | WO1993001210A3 Hcv peptide-antigens and a method of testing for the hepatitis c virus (hcv) |
| 04/15/1993 | DE4133538A1 Verfahren zur gewinnung von lebensmittelfaehigen proteinen aus einer proteinhaltigen substanz A process for recovering lebensmittelfaehigen proteins from a protein-containing substance |
| 04/15/1993 | CA2120946A1 Parathyroid hormone analogues substituted at aa 25.26.27 and use in osteoporosis treatment |
| 04/15/1993 | CA2120763A1 Dendrimeric polychelants |
| 04/15/1993 | CA2120716A1 Method of extracting proteins utilizable in foodstuffs from a protein-containing substance |
| 04/15/1993 | CA2120710A1 Nucleic sequence of the gene associated with x-linked kallmann syndrome corresponding peptide sequences, diagnostic applications |
| 04/15/1993 | CA2120707A1 Human il-3 variants |
| 04/15/1993 | CA2120622A1 Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto |
| 04/15/1993 | CA2120601A1 Sperm surface protein |
| 04/15/1993 | CA2120500A1 Preventing allograft rejection with antibodies to adhesion molecules |
| 04/15/1993 | CA2120370A1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
| 04/15/1993 | CA2120363A1 Lung cancer-associated protein |
| 04/15/1993 | CA2120362A1 Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia |
| 04/15/1993 | CA2120328A1 Purified chitin deacetylase |
| 04/15/1993 | CA2119580A1 Production of gpa neurotrophic factor |
| 04/15/1993 | CA2097056A1 Vaccine against neisseria meningitidis infections |
| 04/15/1993 | CA2096411A1 Subunit vaccine for neisseria meningitidis infections and corresponding purified subunits |
| 04/14/1993 | EP0537105A1 Vectors for bacillus thuringiensis |
| 04/14/1993 | EP0537092A1 Infracellular vesicular vectors and their application in cosmetic and medical compositions and culture media |
| 04/14/1993 | EP0536838A2 Non-A, non-B peptides |
| 04/14/1993 | EP0536741A2 Cyclic VIP analogs |
| 04/14/1993 | EP0536646A2 Recombinant viruses, their application and production |
| 04/14/1993 | EP0536564A2 Method to purify streptolysin O, intact streptolysin O obtainable by this method and its use |
| 04/14/1993 | EP0536563A1 Nuclear inhibitor I-92 and its use for the production of a medicament |
| 04/14/1993 | EP0536520A1 Human interferon beta 2A containing pharmaceuticals |
| 04/14/1993 | EP0536352A1 Therapeutic and preventive vaccines for hiv |